Data as of Oct 21
| -0.10 / -1.36%|
The 5 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 18.00, with a high estimate of 40.00 and a low estimate of 18.00. The median estimate represents a +147.93% increase from the last price of 7.26.
The current consensus among 5 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.